A comparison of the chemiluminescence immunoassay and Crithidia luciliae immunofluorescence test in detecting anti-dsDNA antibodies and assessing the activity of systemic lupus erythematosus
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Objectives This study aimed to compare the YHLO chemiluminescence immunoassay (CLIA) with the Crithidia luciliae immunofluorescence test (CLIFT) to detect anti-dsDNA antibodies and its correlation with disease activity in systemic lupus erythematosus (SLE)... Good correlation and agreement were found between YHLO CLIA and CLIFT. In addition, there was a significant correlation between YHLO CLIA and the SLE Disease Activity Index 2000 (SLEDAI-2K). Spearman’s correlation coefficient between YHLO CLIA and SLEDAI-2K (r = 0.66, p < .01) was higher than that of CLIFT (r = 0.60, p < .01).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Aringer, M., Costenbader, K., Daikh, D., Brinks, R., Mosca, M., Ramsey‐Goldman, R., Smolen, J. S., Wofsy, D., Boumpas, D. T., Kamen, D. L., et al. (2019) · Arthritis & Rheumatology · doi:10.1002/art.40930 · Cited by 2,677
Understanding the Epidemiology and Progression of Systemic Lupus Erythematosus
Pons-Estel, G. J., Alarcón, G. S., Scofield, L., Reinlib, L., & Cooper, G. S. (2010) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2008.10.007 · Cited by 908
Bertsias, G., Ioannidis, J. P. A., Boletis, J., Bombardieri, S., Cervera, R., Dostal, C., Font, J., Gilboe, I. M., Houssiau, F., Huizinga, T., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.070367 · Cited by 762 · cited 1×
“varies from 40% to 90% depending on the detection method.(3,4) During disease development, the immune complexes formed by anti-dsDNA and its antigens are deposited in subcutaneous capillaries, kidneys, and other organs, thus activating the complement system that leads to tissue damage.”
BackgroundPrevention of relapses in systemic lupus erythematosus
Bootsma, H., Spronk, P., de Boer, G., Limburg, P., Kallenberg, C., Derksen, R., Wolters-Dicke, J., Gmelig-Meyling, F., Kater, L., & Hermans, J. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90114-0 · Cited by 290 · cited 1×
“Anti-dsDNA antibody titers are correlated with disease activity, and the detection of antibody titers can effectively monitor treatment.(5,6) At present, there are multiple methods for routinely detecting anti-dsDNA antibodies, such as radioimmunoassay, indirect immunofluorescence, dot immunogold filtration, western b…”
BackgroundFifty years of anti-ds DNA antibodies: are we approaching journey's end?
Isenberg, D. A., Manson, J. J., Ehrenstein, M. R., & Rahman, A. (2007) · Rheumatology · doi:10.1093/rheumatology/kem112 · Cited by 281
Guidelines for immunologic laboratory testing in the rheumatic diseases: Anti‐DNA antibody tests
Kavanaugh, A. F., Solomon, D. H., & The American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines (2002) · Arthritis Care & Research · doi:10.1002/art.10558 · Cited by 225
Förger, F., Matthias, T., Oppermann, M., Becker, H., & Helmke, K. (2004) · Lupus · doi:10.1191/0961203304lu485oa · Cited by 139
The pathogenesis and diagnosis of systemic lupus erythematosus: still not resolved
Rekvig, O. P., & van der Vlag, J. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0428-6 · Cited by 122
Haugbro, K., Nossent, J. C., Winkler, T., Figenschau, Y., & Rekvig, O. P. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.016303 · Cited by 113
Mummert, E., Fritzler, M. J., Sjöwall, C., Bentow, C., & Mahler, M. (2018) · Journal of Immunological Methods · doi:10.1016/j.jim.2018.05.014 · Cited by 86
Research works printed but not linked: 2
- Sinico RA, 2002, J Nephrol, 15, S20
- Ghirardello A, 2011, Clin Exp Rheumatol, 29, 50
Cited by
Ricchiuti, V., Obney, J., Holloway, B., Aure, M. A., Shapiro, M., Bentow, C., & Mahler, M. (2025) · Diagnostics · doi:10.3390/diagnostics15192430 · Cited by 3
“While some assays are particularly useful for the diagnosis of SLE, others might be superior to assess active disease (flares) [22,23].”
Nur, Y., Farah, H. I., Widayat, W., et al. (2026) · RSC Advances · doi:10.1039/d5ra09483f
Metadata
- Authors
- He, S., Wu, X., Li, L., Jiang, K., He, Q., & Xie, L.
- Affiliations
- Guangxi Medical University (CN)
- Corresponding author
- Xie, Li
- Venue
- Lupus
- Publisher
- SAGE Publications
- Published
- 2023-05-24
- Volume
- 32
- Issue
- 8
- Pages
- 936-941
- ISSN
- 0961-2033 (ISSN-L)
- 1477-0962
- OpenAlex
- W4377967954
- Cited by
- 2
- References
- 24
- Citations by year
- 2026: 1 · 2025: 1
- FWCI
- 0.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Lupus (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
- Keywords
- systemic lupus erythematosus, anti-dsDNA antibodies, chemiluminescence immunoassay, disease activity assessment, SLEDAI-2000, assay agreement, sensitivity and specificity, autoantibody detection
- MeSH terms
- Antibodies, Antinuclear, Crithidia, Enzyme-Linked Immunosorbent Assay, Fluorescent Antibody Technique, Humans, Immunoassay, Lupus Erythematosus, Systemic, Sensitivity and Specificity, Luminescence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A comparison of the chemiluminescence immunoassay and Crithidia luciliae immunofluorescence test in detecting anti-dsDNA antibodies and assessing the activity of systemic lupus erythematosus. https://app.cochat.ai/papers/10.1177/09612033231179888
- The paper
- He, S., Wu, X., Li, L., Jiang, K., He, Q., & Xie, L. (2023). A comparison of the chemiluminescence immunoassay and Crithidia luciliae immunofluorescence test in detecting anti-dsDNA antibodies and assessing the activity of systemic lupus erythematosus. Lupus. https://doi.org/10.1177/09612033231179888
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.